Cart
0

Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2016-2024

Get 20% Free Customization In This Report
LI_161795
Pages: 267
May 2018 | 11624 Views
 
Author's : Prateeksha Kaul and Pallavi Jaiswal
Tables: 135
Charts: 34
 

Continuous Glucose Monitoring Systems Market Overview:

The Global Continuous Glucose Monitoring Systems Market was valued at $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% from 2018 to 2024. Continuous glucose monitoring systems helps to manage diabetes by providing real time values of the glucose levels and alerts to the patient in the event of hypo or hyperglycemia. This helps reduce the probability of any complications related to diabetes. In addition, CGMS offers varied benefits over other glucose monitors in monitoring the blood glucose levels of ICU patients. The major factors that drive the growth include surge in geriatric population and high prevalence of population suffering from diabetes. However, lack of adequate reimbursement for devices is the key barrier to the adoption of the devices.

 

Get more information on this report : Request Sample Pages

High Incidence of Diabetes

According to the International Diabetes Federation, the number of diabetic population is expected to reach 642 million by the year 2040 as compared to 415 million patients in 2015, worldwide. Thus, one out of every ten adults is expected to have diabetes by 2040, which reveals the graveness of this pandemic. Therefore, the treatment, and management of diabetes is expected to be the prime focus areas of healthcare departments and stakeholders, globally. The increase in incidence of diabetic cases would provide high market growth and opportunities, which in turn will attract and compel numerous market players to develop innovative products or product line extensions. The aforementioned factors are expected to boost the overall growth of the market.

Get more information on this report : Request Sample Pages

Market Segmentation

The market is categorized based on component, demographics, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years. On the basis of demographics, CGMS devices are categorized into child population (≤14 years) and adult population (>14 years). The report includes comprehensive geographical analysis and segmentation of geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report : Request Sample Pages

The key companies operating in the market include Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., Insulet Corporation, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global continuous glucose monitoring systems market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis from 2016 to 2024 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
  • An extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Continuous Glucose Monitoring Systems Market Key Segments:

By Component

  • Sensors
  • Transmitters & Receivers
  • Integrated Insulin Pumps

By Demographics

  • Child Population (≤14 years)
  • Adult Population (>14 years)

By End User

  • Diagnostics/Clinics
  • ICUs
  • Home Healthcare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Norway
    • Sweden
    • Denmark
    • Finland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Venezuela
    • Argentina
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO Perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition
3.2. Need for glucose monitoring systems

3.2.1. Diabetes-a pandemic

3.2.1.1. Type 1 diabetes
3.2.1.2. Type-2 diabetes
3.2.1.3. Prediabetes and gestational diabetes mellitus (GDM)
3.2.1.4. Gestational diabetes mellitus (GDM)
3.2.1.5. Secondary diabetes
3.2.1.6. Global healthcare expenditure on diabetes

3.3. Key Findings

3.3.1. Top investment pockets
3.3.2. Top winning strategies
3.3.3. Value Chain Analysis

3.4. Patent analysis

3.4.1. Patent analysis, by market participant
3.4.2. U.S. patent analysis, by market participant
3.4.3. Patent analysis, by year

3.5. Market Share Analysis, 2017
3.6. Government Regulations

3.6.1. FDA regulations (21CFR820)

3.6.1.1. Objective and Scope of FDA 21CFR820

3.6.2. ISO regulations (ISO 13485:2003)

3.6.2.1. Objective and Scope of ISO 13485:2003

3.7. Reimbursement Scenario
3.8. Market dynamics

3.8.1. Drivers

3.8.1.1. Benefits of CGMS over POC glucometers
3.8.1.2. Rise in incidence of diabetes cases
3.8.1.3. Technological advancements

3.8.2. Restraints

3.8.2.1. Adverse effects and accuracy
3.8.2.2. Reimbursement and stringent regulatory issues

3.8.3. Opportunities

3.8.3.1. High adoption rate of CGMS in home healthcare and ICUs
3.8.3.2. Increase in product awareness
3.8.3.3. High undiagnosed patient population

3.8.4. Impact analyses

Chapter: 4: CONTINOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT

4.1. Overview

4.1.1. Market size and forecast

4.2. Sensors

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Transmitters & Receivers

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Integrated Insulin pumps

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

Chapter: 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS

5.1. Overview

5.1.1. Market size and forecast

5.2. Adult Population (>14 years)

5.2.1. Market size and forecast

5.3. Children Population (≤14 years)

5.3.1. Market size and forecast

Chapter: 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Diagnostic centers/clinics

6.2.1. Market size and forecast

6.3. ICUs

6.3.1. Market size and forecast

6.4. Home Healthcare

6.4.1. Market size and forecast

Chapter: 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America continuous glucose monitoring systems market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. continuous glucose monitoring systems market size and forecast, by component
7.2.2.1.2. U.S. continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.1.3. U.S. continuous glucose monitoring systems market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada continuous glucose monitoring systems market size and forecast, by component
7.2.2.2.2. Canada continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.2.3. Canada continuous glucose monitoring systems market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico continuous glucose monitoring systems market size and forecast, by component
7.2.2.3.2. Mexico continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.3.3. Mexico continuous glucose monitoring systems market size and forecast, by end user

7.2.3. North America continuous glucose monitoring systems market size and forecast, by component
7.2.4. North America continuous glucose monitoring systems market size and forecast, by demographics
7.2.5. North America continuous glucose monitoring systems market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe continuous glucose monitoring systems market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Germany continuous glucose monitoring systems market size and forecast, by component
7.3.2.1.2. Germany continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.1.3. Germany continuous glucose monitoring systems market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. France continuous glucose monitoring systems market size and forecast, by component
7.3.2.2.2. France continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.2.3. France continuous glucose monitoring systems market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. UK continuous glucose monitoring systems market size and forecast, by component
7.3.2.3.2. UK continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.3.3. UK continuous glucose monitoring systems market size and forecast, by end user

7.3.2.4. Spain

7.3.2.4.1. Spain continuous glucose monitoring systems market size and forecast, by component
7.3.2.4.2. Spain continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.4.3. Spain continuous glucose monitoring systems market size and forecast, by end user

7.3.2.5. Italy

7.3.2.5.1. Italy continuous glucose monitoring systems market size and forecast, by component
7.3.2.5.2. Italy continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.5.3. Italy continuous glucose monitoring systems market size and forecast, by end user

7.3.2.6. Netherlands

7.3.2.6.1. Netherlands continuous glucose monitoring systems market size and forecast, by component
7.3.2.6.2. Netherlands continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.6.3. Netherlands continuous glucose monitoring systems market size and forecast, by end user

7.3.2.7. Norway

7.3.2.7.1. Norway continuous glucose monitoring systems market size and forecast, by component
7.3.2.7.2. Norway continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.7.3. Norway continuous glucose monitoring systems market size and forecast, by end user

7.3.2.8. Sweden

7.3.2.8.1. Sweden continuous glucose monitoring systems market size and forecast, by component
7.3.2.8.2. Sweden continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.8.3. Sweden continuous glucose monitoring systems market size and forecast, by end user

7.3.2.9. Denmark

7.3.2.9.1. Denmark continuous glucose monitoring systems market size and forecast, by component
7.3.2.9.2. Denmark continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.9.3. Denmark continuous glucose monitoring systems market size and forecast, by end user

7.3.2.10. Finland

7.3.2.10.1. Finland continuous glucose monitoring systems market size and forecast, by component
7.3.2.10.2. Finland continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.10.3. Finland continuous glucose monitoring systems market size and forecast, by end user

7.3.2.11. Rest of Europe

7.3.2.11.1. Rest of Europe continuous glucose monitoring systems market size and forecast, by component
7.3.2.11.2. Rest of Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.11.3. Rest of Europe continuous glucose monitoring systems market size and forecast, by end user

7.3.3. Europe continuous glucose monitoring systems market size and forecast, by component
7.3.4. Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.5. Europe continuous glucose monitoring systems market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific continuous glucose monitoring systems market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan continuous glucose monitoring systems market size and forecast, by component
7.4.2.1.2. Japan continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.1.3. Japan continuous glucose monitoring systems market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. China continuous glucose monitoring systems market size and forecast, by component
7.4.2.2.2. China continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.2.3. China continuous glucose monitoring systems market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. India continuous glucose monitoring systems market size and forecast, by component
7.4.2.3.2. India continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.3.3. India continuous glucose monitoring systems market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Australia continuous glucose monitoring systems market size and forecast, by component
7.4.2.4.2. Australia continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.4.3. Australia continuous glucose monitoring systems market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea continuous glucose monitoring systems market size and forecast, by component
7.4.2.5.2. South Korea continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.5.3. South Korea continuous glucose monitoring systems market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.2.6.2. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.6.3. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user

7.4.3. Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.4. Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.5. Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA continuous glucose monitoring systems market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil continuous glucose monitoring systems market size and forecast, by component
7.5.2.1.2. Brazil continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.1.3. Brazil continuous glucose monitoring systems market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia continuous glucose monitoring systems market size and forecast, by component
7.5.2.2.2. Saudi Arabia continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.2.3. Saudi Arabia continuous glucose monitoring systems market size and forecast, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Africa continuous glucose monitoring systems market size and forecast, by component
7.5.2.3.2. South Africa continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.3.3. South Africa continuous glucose monitoring systems market size and forecast, by end user

7.5.2.4. Venezuela

7.5.2.4.1. Venezuela continuous glucose monitoring systems market size and forecast, by component
7.5.2.4.2. Venezuela continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.4.3. Venezuela continuous glucose monitoring systems market size and forecast, by end user

7.5.2.5. Argentina

7.5.2.5.1. Argentina continuous glucose monitoring systems market size and forecast, by component
7.5.2.5.2. Argentina continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.5.3. Argentina continuous glucose monitoring systems market size and forecast, by end user

7.5.2.6. Rest of LAMEA

7.5.2.6.1. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.2.6.2. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.6.3. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by end user

7.5.3. LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.4. LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.5. LAMEA continuous glucose monitoring systems market size and forecast, by end user

Chapter: 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. A. Menarini Diagnostics S.r.l.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio

8.3. DexCom, Inc.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. Echo Therapeutics, Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments

8.5. F. Hoffmann-La Roche Ltd.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. GlySens Incorporated

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.6.4. Key strategic moves and developments

8.7. Insulet Corporation

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. Johnson & Johnson

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. Medtronic Plc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. Senseonics Holdings, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL PREVALENCE OF TYPE-2 DIABETES (2014)
TABLE 02. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 03. SENSORS MARKET, BY REGION, 2016-2024 ($MILLION)
TABLE 04. TRANSMITTERS & RECEIVERS MARKET, BY REGION, 2016-2024 ($MILLION)
TABLE 05. INTEGRATED INSULIN PUMPS MARKET, BY REGION, 2016-2024 ($MILLION)
TABLE 06. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 07. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION (>14YEARS), BY REGION, 2016-2024 ($MILLION)
TABLE 08. TYPE-1 DIABETES (0-14 YEARS), 2015
TABLE 09. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION (<14YEARS), BY REGION, 2016-2024 ($MILLION)
TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END-USER, 2016-2024 ($MILLION)
TABLE 11. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIAGNOSTIC CENTERS/CLINICS, BY REGION, 2016-2024 ($MILLION)
TABLE 12. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ICUS, BY REGION, 2016-2024 ($MILLION)
TABLE 13. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY REGION, 2016-2024 ($MILLION)
TABLE 14. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2016-2024 ($MILLION)
TABLE 15. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2024 ($MILLION)
TABLE 16. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 17. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 18. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 19. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 20. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 21. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 22. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 24. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 25. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 26. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 27. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 28. PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS) IN EUROPE, 2015
TABLE 29. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2024 ($MILLION)
TABLE 30. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 31. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 32. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 33. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 34. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 35. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 36. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 37. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 38. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 39. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 40. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 41. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 42. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 43. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 44. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 45. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 46. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 47. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 48. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 49. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 50. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 51. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 52. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 53. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 54. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 55. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 56. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 57. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 58. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 59. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 60. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 61. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 62. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 63. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 64. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 65. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 66. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2024 ($MILLION)
TABLE 67. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 68. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 69. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 70. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 71. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 72. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 73. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 74. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 76. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 77. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 78. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 79. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 80. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 81. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 85. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 86. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 87. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 88. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2016-2024 ($MILLION)
TABLE 89. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 90. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 91. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 92. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 93. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 94. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 95. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 96. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 97. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 98. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 99. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 100. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 101. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 102. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 103. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 104. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 105. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 106. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 107. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2016-2024 ($MILLION)
TABLE 108. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS, 2016-2024 ($MILLION)
TABLE 109. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2016-2024 ($MILLION)
TABLE 110. ABBOTT: COMPANY SNAPSHOT
TABLE 111. ABBOTT: OPERATING SEGMENTS
TABLE 112. ABBOTT: PRODUCT PORTFOLIO
TABLE 113. A. MENARINI DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 114. A. MENARINI DIAGNOSTICS: PRODUCT SEGMENTS
TABLE 115. A. MENARINI DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 116. DEXCOM: COMPANY SNAPSHOT
TABLE 117. DEXCOM: PRODUCT PORTFOLIO
TABLE 118. ECHO THERAPEUTICS: COMPANY SNAPSHOT
TABLE 119. ECHO THERAPEUTICS: OPERATING SEGMENTS
TABLE 120. ECHO THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 121. ROCHE: COMPANY SNAPSHOT
TABLE 122. ROCHE: OPERATING SEGMENTS
TABLE 123. ROCHE: PRODUCT PORTFOLIO
TABLE 124. GLYSENS: COMPANY SNAPSHOT
TABLE 125. GLYSENS: PRODUCT PORTFOLIO
TABLE 126. INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 127. INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 128. J&J: COMPANY SNAPSHOT
TABLE 129. J&J: OPERATING SEGMENTS
TABLE 130. MEDTRONIC: COMPANY SNAPSHOT
TABLE 131. MEDTRONIC: OPERATING SEGMENTS
TABLE 132. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 133. SENSEONICS: COMPANY SNAPSHOT
TABLE 134. SENSEONICS: PRODUCT SEGMENTS
TABLE 135. SENSEONICS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SEGMENTATION
FIGURE 02. PREVALENCE OF TYPE 1 DIABETES (AGE GROUP OF <15 YEARS), BY GEOGRAPHY (2015)
FIGURE 03. SIMILAR PREDISPOSITION AND RISK FACTORS FOR PREDIABETES AND TYPE-2 DIABETES
FIGURE 04. TOP TEN COUNTRIES/TERRITORIES FOR DIABETES-RELATED HEALTH EXPENDITURE, 2015
FIGURE 05. GLOBAL FINANCIAL BURDEN OF DIABETES, BY GEOGRAPHY
FIGURE 06. TOP INVESTMENT POCKETS
FIGURE 07. TOP WINNING STRATEGIES, BY YEAR, 2014-2018*
FIGURE 08. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2018* (%)
FIGURE 09. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*
FIGURE 10. VALUE CHAIN OF GLOBAL CGMS MARKET
FIGURE 11. PATENTS REGISTERED/APPROVED IN THE WORLD 2015-2018
FIGURE 12. PATENT ANALYSIS BY MARKET PARTICIPANT, 2015-2018
FIGURE 13. U.S.: PATENT ANALYSIS BY MARKET PARTICIPANT, 2015-2018
FIGURE 14. PATENTS ANALYSIS BY YEAR, 2015-2018
FIGURE 15. MARKET SHARE ANALYSIS OF GLOBAL CGMS MARKET, 2017
FIGURE 16. UNDIAGNOSED PATIENT POPULATION IN 2015 (MILLION)
FIGURE 17. IMPACT ANALYSES
FIGURE 18. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 19. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 20. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 21. DEXCOM: NET SALES, 2015-2017 ($MILLION)
FIGURE 22. DEXCOM: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 23. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 24. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25. INSULET CORPORATION: REVENUE, 2015-2017 ($MILLION)
FIGURE 26. INSULET CORPORATION: REVENUE SHARE BY OPERATIONS, 2017 (%)
FIGURE 27. INSULET CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 28. J&J: NET SALES, 2017-2016 ($MILLION)
FIGURE 29. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. SENSEONICS: NET SALES, 2015-2017 ($MILLION)

 

The global continuous glucose monitoring systems market is characterized by the ability to manage diabetes by providing real time values of the glucose levels and alerts to the patient in the event of hypo or hyperglycemia. This helps reduce the probability of any complications related to diabetes. In addition, CGMS offers varied benefits over other glucose monitors in monitoring the blood glucose levels of ICU patients. The conventional POC and SMBG devices imparts discomfort or pain in patients. Therefore, CGMS are preferred over SMBG/POC devices.

Undiagnosed geriatric patient population will provide attractive market opportunities for integrated CGMS developers. This is due to the fact that the geriatric patients often suffer from multiple and chronic diseases, which require various medications and at much higher frequency intervals, as compared to the other cohorts. In addition, chances to skip or forget the hypoglycemic medications are higher in geriatric patients. CGMS devices automatically deliver the insulin dosage in such patients without any efforts. Due to these reasons, geriatric patients are more amenable to integrated CGMS devices that help maintain tight glycemic control (TGC) and auto-deliver insulin as per the circadian clock.

Based on region, North America is estimated to dominate the CGMS market throughout the forecast period, owing to increase in incidence of people suffering from diabetes, followed by Europe and Asia-Pacific.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Continuous Glucose Monitoring Systems Market- Global Opportunity Analysis and Industry Forecast, 2016-2024

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quarterly industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo